K ϩ (KATP) channels are composed of pore-forming Kir6.x subunits and regulatory sulfonylurea receptor (SUR) subunits. SURs are ATP-binding cassette proteins with two nucleotide-binding folds (NBFs) and binding sites for sulfonylureas, like glibenclamide, and for channel openers. Here we report the identification and functional characterization of four novel splice forms of guinea pig SUR1. Three splice forms originate from alternative splicing of the region coding for NBF1 and lack exons 17 (SUR1⌬17), 19 (SUR1⌬19), or both (SUR1⌬17⌬19). The fourth (SUR1C) is a COOH-terminal SUR1-fragment formed by exons 31-39 containing the last two transmembrane segments and the COOH terminus of SUR1. RT-PCR analysis showed that these splice forms are expressed in several tissues with strong expression of SUR1C in cardiomyocytes. Confocal microscopy using enhanced green fluorescent protein-tagged SUR or Kir6.x did not provide any evidence for involvement of these splice forms in the mitochondrial K ATP channel. Only SUR1 and SUR1⌬17 showed high-affinity binding of glibenclamide (KdϷ 2 nM in the presence of 1 mM ATP) and formed functional K ATP channels upon coexpression with Kir6.2.
ATP-SENSITIVE POTASSIUM CHANNELS (K ATP channels) link the metabolic state of a cell to excitability: cytosolic ATP inhibits K ATP channels, whereas cytosolic MgADP activates these channels. K ATP channels are involved in many physiological processes including insulin secretion by pancreatic ␤ cells, regulation of vascular tone, and neuronal excitability. The molecular components of K ATP channels have been cloned (1, 22, 23, 25) , and the channel has been identified as an octameric assembly of four channel-forming Kir6.x subunits and four regulatory sulfonylurea receptor (SUR) subunits (14, 45) . The Kir6.x subunits belong to the family of inwardly rectifying potassium channels. The SUR is a member of the ATP-binding cassette (ABC) superfamily and contains 17 transmembrane helices, which are arranged in three clusters. SUR possesses two intracellular nucleotide-binding folds (NBFs) as well as binding sites for channel openers and for blockers of the sulfonylurea type (3) . Binding sites of channel openers and blockers have been localized to the COOH-terminal transmembrane domain complex of SUR (4, 5, 30, 48) , with negative allosteric coupling between these sites (9, 41) . Association of Kir6.x and SUR subunits is a prerequisite for trafficking of the K ATP channel octamer to the cell membrane. Both subunits contain several anterograde and retrograde trafficking signal sequences (44, 51) that determine cell surface expression.
The Kir and the SUR subunits of K ATP channels are both encoded by two genes, Kir6.1 and Kir6.2, and SUR1 and SUR2. Alternative splicing of the last exon of SUR2 gives rise to the isoforms SUR2A and B (for review, see Refs. 2 and 3). Channel diversity is created by different combinations of Kir6.x and SURx subunits: the pancreatic K ATP channel prototype (Kir6.2/ SUR1) is blocked by the sulfonylurea glibenclamide with high potency (IC 50 Ͻ 1 nM) and shows activation by diazoxide (16, 22) . The myocardial K ATP channel prototype (Kir6.2/SUR2A) shows a lower affinity for glibenclamide (IC 50 ϭ 26 nM; Ref. 38) and, in the absence of MgADP, no activation by diazoxide (23, 32) . The vascular K ATP channel prototype (Kir6.1/SUR2B) shows a similar sensitivity for glibenclamide (IC 50 ϭ 43 nM; Ref. 37) , although it is activated by diazoxide (25) . However, expression of these isoforms is not restricted to these tissues. K ATP channels have also been described in brain (26, 27, 50) , kidney (8) , and coronary endothelial cells (29) . A mitochondrial K ATP channel has also been postulated (24) , but its molecular composition remains elusive (28, 43) .
The SUR2 gene contains 39 exons, and several different splice forms have been found in which the last exon is altered (SUR2A and SUR2B; Refs. 23, 25, and 49) or internal exons are skipped (12, 13, 39) . The regions of the NBFs form large cytosolic loops and have attracted particular attention in the search for new splice forms, because alternative splicing may change pharmacological properties of the resulting K ATP chan-nels but would not change membrane topology. Changes in the NBFs would be expected to modify the binding of nucleotides and, by allosteric interactions, also the binding of K ϩ channel openers and sulfonylurea derivatives. A SUR2 splice form lacking exon 17 (SUR2⌬17) was found by RT-PCR in several mouse tissues, including heart, skeletal muscle, bladder, small intestine, and prostate (13, 15) . Heterologous coexpression of this splice form with Kir6.2 shows a small decrease in ATP-sensitivity (13) . Another SUR2 splice form identified in cardiac tissue (12) lacks exon 14 but could not be functionally expressed. In the case of SUR1, a splice form lacking exon 33 has been described that shows unique electrophysiological properties (39) . The lack of exon 33 introduces a frame shift that leads to a deletion of the second nucleotide binding domain (NBF2). A second SUR1 splice variant lacking exon 31 has not been functionally characterized (6) . Here we describe four novel splice forms of SUR1. Three of them lack exon 17 (SUR1⌬17) and/or exon 19 (SUR1⌬17⌬19 or SUR1⌬19), which are both located in the coding region of the first NBF. The fourth splice form is a truncated COOH-terminal SUR1 fragment (SUR1C). Functional analysis showed that only SUR1 containing all the exons (referred to as SUR1 in the following text) and SUR1⌬17 exhibit specific binding of glibenclamide and give rise to ATP-sensitive channels when coexpressed with Kir6.2 subunits.
MATERIALS AND METHODS

RT-PCR of splice forms.
RNA from different guinea pig tissues was prepared using a modified single-step method (10) . RNA (1 g) was reverse transcribed with Superscript reverse transcriptase (Life Technologies). As a positive control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression was tested by RT-PCR (29) . RNA from ventricular cardiomyocytes and capillary endothelial cells was prepared and reverse transcribed as described previously (34) . The purity of cell fractions was verified by RT-PCR experiments by using the cell-specific markers troponin T and endothelin-1 (34) . Two degenerated primers were used to amplify both SUR1 and SUR2 from RT samples, with the forward primer located on exons 15 and 16 (5Ј-AGGYCAGCTRACYA-TGATYGTRGG-3Ј) and the reverse primer located on exon 21 (5Ј-ATGTCTGGCTGMAGRGAGCAGGC-3Ј). The SUR1C fragment was amplified with primers located in the 5Ј-noncoding region of the SUR1C cDNA (see below) (forward: 5Ј-GAAGGGTGGCTATGATCACTGATGGG-3Ј) and in exon 31 (reverse: 5Ј-CACAGGCACCGATGTACTCCATTCG-3Ј). PCR products of different sizes, depending on the splice form (see RESULTS), were amplified by using AmpliTaq Gold DNA polymerase (Applied Biosystems) for 35 cycles at 94°C for 1 min, 55°C for 30 s, and 73°C for 30 s (with an initial polymerase activation at 94°C for 6 min and a final elongation at 73°C for 5 min). Finally, PCR products were visualized on a 4% Nusieve agarose gel and directly sequenced. In addition, PCR products were cloned into pBluescript SKϩ vector (Life Technologies) and sequenced to identify minor SUR1 or SUR2 splice forms.
Isolation of SUR1C from a guinea pig cardiac cDNA library. A cardiac ventricle cDNA library was constructed, ligated into the TriplEx vector (Clontech, Palo Alto, CA), and screened with a COOH-terminal gpSUR1 fragment as described previously (29) . Total sequence information was obtained from the converted pTriplEx. For 5Ј and 3Ј RACE (rapid amplification of cDNA ends), a Marathon cDNA was synthesized from 5 g of poly(A) ϩ RNA as described previously (36) .
Construction of SUR1 expression vectors. To construct a SUR1 expression vector of the different splice forms, an ApaI/XhoI cassette was amplified from rat heart, kidney, and brain cDNA by using rat SUR1 specific primers (forward: 5Ј-CGAGAAGAAGTCCGGGACCTCT-3Ј, reverse: 5Ј-CTGT-CCTCTTGTCATCCCGGAG-3Ј). The PCR products were digested with ApaI and XhoI and cloned into pBluescript SKϩ vector. Rat SUR1⌬17 and SUR1⌬19 splice forms were identified by DNA sequencing. Finally, the ⌬17 and ⌬19 cassettes were subcloned into rat SUR1/pBF1 (kindly provided by Dr. B. Fakler, Tü bingen, Germany). For heterologous expression in mammalian cells, the ratSUR1 splice forms were subcloned into pcDNA3.1 (Invitrogen, Karlsruhe, Germany) or pEGFP-C1 (NH 2-terminal fusion of the enhanced green fluorescent protein; Clontech) vectors. For expression of the SUR1C splice form, the guinea pig clone was used.
Cell culture and transfections. Human embryonic kidney (HEK)-293 cells were cultured as described previously (19, 20) in minimum essential medium containing glutamine, supplemented with 10% fetal bovine serum and 20 g/ml gentamycin. COS-7 cells were grown in DMEM (Life Technologies) supplemented with 10% fetal bovine serum and 10 g/ml streptomycin-ampicillin mixture (Biochrom, Berlin, Germany). For binding studies and electrophysiological measurements, cells were transfected with mammalian expression vector pcDNA3.1 (Invitrogen) containing the coding sequence of rat SUR1 (rSUR1; GenBank accession no. X97279; Ref. 1), the different splice forms of SUR1 mentioned above, or pcDNA3.1 vector alone with Lipofectamine and OptiMem (Invitrogen) (19) . For electrophysiological studies, SUR1 splice forms were cotransfected transiently with Kir6.2 (GenBank accession no. D50581; Ref. 22 ) at a molar plasmid ratio of 1:1. Here, pEGFP-C1 vector (Clontech), encoding for green fluorescent protein, was added for easier identification of transfected cells. Two to four days after transfection, cells were used for binding studies and electrophysiological experiments. Cell lines stably transfected with SUR1 wild-type or SUR1 splice forms were isolated in the presence of 700 g geneticin/ml in the first 3 wk and 300 g geneticin/ml medium; thereafter, 1 wk before experiments, the antibiotic was withdrawn.
For confocal microscopy, rSUR1 splice forms and guinea pig Kir6.1 cDNAs (GenBank accession nos. AF183918 and AF183919; Ref. 29) were fused to the EGFP gene by cloning into the expression vector pEGFP-C1 or -N1 (Clontech). Subcellular localization vectors were used to label mitochondria (mitoGFP: targeting sequence of the ␤-subunit of F1-ATPase from Neurospora crassa was ligated into the pEGFP-N1 vector) and the endoplasmic reticulum (pEYFP-ER, Clontech). HEK-293 or COS-7 cells were transiently transfected by using Lipofectamine 2000 as transfection reagent and incubated for 24 h at 37°C.
Confocal microscopy. Confocal images were produced using a FV300 confocal laser scanning microscope (Olympus, Hamburg, Germany). Images of 600 ϫ 800 pixels were obtained via a ϫ60 oil-immersion objective lens (numerical aperture 1.4). Laser intensity was set at 6%, and the pinhole was optimized for the ϫ60 objective. COS-7 cells were grown on coverslips, and mitochondria were labeled by incubation with 50 nM MitoTracker red (Molecular Probes, Leiden, The Netherlands) for 7-8 min at ϳ30°C. MitoTracker red was excited with the 568-nm line of a Kr-Ar ion laser, and red fluorescence was detected at Ͼ585 nm. We avoided repeat-edly scanning MitoTracker red-labeled cells because we found that repeated excitation induced a change in mitochondrial morphology, probably secondary to the phototoxic effects of this indicator as previously described (31) . Simultaneous to MitoTracker red excitation, EGFP was excited at 488 nm, and green fluorescence was detected at 510-540 nm. Areas of overlap between the red and green signals were seen as yellow.
Equilibrium-binding experiments. Membranes were prepared from HEK-293 cells at 80% confluence (16 million cells/dish) (19) . Cells were easily detached by repeated rinsing with medium in the absence of trypsin and centrifuged at 37°C for 6 min at 500 g. The pelleted cells were lysed by addition of 5 ml/dish of ice-cold hypotonic buffer containing 10 mM HEPES and 1 mM EGTA (pH 7.4), and the lysate was centrifuged (100,000 g) for 60 min at 4°C. The resulting membrane pellet was resuspended in a buffer containing 5 mM HEPES, 5 mM KCl, and 139 mM NaCl (pH 7.4, 4°C) at a protein concentration of 0.7 mg/ml and frozen at Ϫ80°C. In the binding assay, membranes (final protein concentration 0.03-0.4 mg/ml) were added to the incubation buffer (139 mM NaCl, 5 mM KCl, 5 mM HEPES, and 2.2 mM MgCl 2) supplemented with the radioligand [1-6 nM [ (21) were carried out in HEK-293 cells cotransfected with KATP channel subunits and green fluorescent protein (GFP). Patch pipettes were drawn from borosilicate glass capillaries (GC 150T; Harvard Apparatus, Edenbridge, UK) and heat polished using a horizontal microelectrode puller (Zeitz, Augsburg, Germany). For inside-out patches, bath and pipette were filled with a high-K ϩ Ringer solution containing (in mM) 142 KCl, 2.8 NaCl, 1 MgCl2, 1 CaCl2, 11 D(ϩ)-glucose, and 10 HEPES, titrated to pH 7.4 with NaOH at 22°C. After being filled with buffer, pipettes had a resistance of 1-1.5 M⍀. After the patch was excised, the pipette was moved in front of a superfusion cannula filled with high-K ϩ EGTA Ringer solution containing 143 mM KCl, 0.85 mM MgCl2, 1 mM CaCl2, 5 mM EGTA, 11 mM D(ϩ)-glucose, and 10 mM HEPES (pH 7.2, 22°C). ATP was added to the solution, keeping free Mg 2ϩ constant (0.7 mM), and KCl was reduced to maintain osmolarity. The solution with low free Mg 2ϩ contained 142 mM KCl, 0.5 mM CaCl2, 0.5 mM MgCl2, 5 mM EDTA, 10 mM HEPES, and 11 mM D-glucose (pH 7.2, 22°C). The free Ca 2ϩ and Mg 2ϩ concentrations were calculated to be 5.4 and 270 nM, respectively (19) . ATP was added in appropriate amounts and had only minor effects on free Ca 2ϩ or Mg 2ϩ
. After addition of 1 mM ATP, the concentration of MgATP was 2.3 M. Excised patches were clamped at a transmembrane potential of Ϫ50 mV.
Experiments using the whole cell configuration were performed as described in Ref. 37 . The bath solution contained (in mM) 142 NaCl, 2.8 KCl, 1 MgCl2, 1 CaCl2, 11 D(ϩ)-glucose, and 10 HEPES, titrated to pH 7.4 with NaOH at 37°C. Patch pipettes were filled with (in mM) 132 K-glutamate, 10 NaCl, 2 MgCl2, 10 HEPES, 1 EGTA, 1 Li2GDP, and 0.3 Na2ATP, titrated to pH 7.2 with NaOH. Resistance after filling was 3-5 M⍀. Cells were clamped at Ϫ60 mV. Data were recorded with an EPC9 amplifier (HEKA, Lambrecht, Germany) using Pulse software. Signals were filtered at 200 Hz with the four-pole Bessel filter of the EPC9 amplifier and sampled at 1 kHz.
Data analysis and statistics. Inhibition curves from radioligand binding and patch-clamp experiments were analyzed according to the logistic equation
where A denotes the relative extent of inhibition at saturation (A ϭ 100 for complete inhibition of the current by ATP), nH is the Hill coefficient, and pIC50 is the midpoint of the curve with pIC50 ϭ Ϫlog IC50; x is the concentration of the compound under study with px ϭ Ϫlog x. In binding experiments, two-component analysis with nH ϭ 1 was sometimes required. The dependence of the IC50 value on the concentration of the radioligand, L, was calculated according to the equation (11) IC 50 
where Ki is the inhibition constant and Kd is the equilibrium dissociation constant of the radioligand.
Fits of the equations to the experimental data were performed according to the method of least squares using the programs FigP (Biosoft, Cambridge, UK) or SigmaPlot (SPSS, Chicago, IL). Assuming that amplitudes and pK values are normally distributed, significance of difference between the parameters was calculated by the two-tailed unpaired Student's t-test or by one-way analysis of variance by using the program GraphPad Prism, version 3.0 (GraphPad Software, San Diego, CA). In the text, the IC 50 or K values are followed by the 95% confidence interval in parentheses.
Materials.
[ 3 H]GBC [specific activity 1.85 TBq (50 Ci)/ mmol] was purchased from Perkin Elmer Life Science Products (Bad Homburg, Germany). The reagents and media used for cell culture and transfection were from Invitrogen. Na 2ATP and Li2GDP were obtained from Roche Molecular Biochemicals (Mannheim, Germany) and glibenclamide from Sigma (Deisenhofen, Germany). The following drugs were kind gifts of the pharmaceutical companies indicated: diazoxide (Essex Pharma, Munich, Germany), meglitinide (Aventis, Frankfurt, Germany), and l-pinacidil (Leo Pharmaceuticals, Ballerup, Denmark). K ATP channel modulators were dissolved in dimethyl sulfoxide/ethanol [50/50 (vol/vol)] and further diluted with the same solvent or with incubation buffer (final solvent concentration Ͻ 0.3%).
RESULTS
Identification of guinea pig SUR1 and SUR2 splice forms.
To investigate alternative splicing of the short exons of the first NBF of guinea pig SUR subunits, we designed primers for amplification of exons 16-20 (SUR1) or 16-19 (SUR2) from both gpSUR1 and gp-SUR2 in one PCR reaction (Fig. 1) . After the PCR products were separated on a 4% Nusieve agarose gel, bands of 323, Ϸ290, 252, 224, and 191 bp were identified in several tissues and cell fractions (Fig. 2) . Direct sequencing or cloning of PCR products revealed that these bands correspond to the following gpSUR splice forms: gpSUR1 (323 bp); gpSUR2 (291 bp); and gp-SUR1⌬17 (286 bp) as a component of the Ϸ290-bp PCR product; gpSUR2⌬17 (252 bp); gpSUR1⌬19 (224 bp); and gpSUR1⌬17⌬19 (191 bp). Direct sequencing of the second PCR band shown in Fig. 2A revealed only the sequence of gpSUR2. However, cloning and sequencing of isolated clones showed that a minor portion of this band (Ͻ10%) represented gpSUR1⌬17, indicating that the band contained a mixture of two PCR products (291 and 286 bp). Figure 1A shows an alignment of the partial cDNA and amino acid sequences of gpSUR1 (GenBank accession no. AY050167) and gpSUR2 (GenBank accession no. AY050168). Sequence comparison showed that the amplified gpSUR1 sequence is highly homologous (Ͼ90% identity on the amino acid level) to its human, rat, or hamster orthologs (Fig. 1B) . The short exon 17 is less conserved (Ϸ60% identity), with two additional amino acids in the guinea pig sequence compared with human. The gpSUR2 sequence showed an even higher homology to orthologous sequences (Ͼ97% identity).
Tissue distribution of SUR splice forms. Figure 2A shows the RT-PCR analysis of several guinea pig tissues. The different gpSUR splice forms were detected in significant amounts in all tissues tested ( Fig. 2A) , except for gpSUR1⌬17⌬19, which was found only in the cardiomyocyte fraction (see SUR expression in heart cell fraction). The relative amounts of the PCR products varied from organ to organ. gpSUR1 was detected in all tissues tested, although the band observed in heart was very faint. gpSUR1⌬19 was detected at low levels in brain, lung, heart, and pancreas and at even lower amounts in other tissues. The detection of gpSUR1⌬17 was difficult because the size of the PCR product was the same as for gpSUR2. However, from sequencing of cloned PCR products, it became clear that the number of gpSUR1⌬17 clones were always Ͻ10% of the total clones tested, indicating that this isoform is a minor splice variant. gpSUR2 was particularly abundant in brain, heart, kidney, and liver. gpSUR2⌬17 was found at high RNA levels in stomach and, in agreement with previous work (13), in skeletal muscle. Note that exon 18 of SUR2 is equivalent to exon 19 of SUR1 (Fig. 1B) ; thus SUR2⌬18 would correspond to SUR1⌬19. However, we have not detected a gpSUR2 splice form without exon 18.
SUR expression in heart cell fraction. Cell-specific RT-PCR analysis was carried out with isolated cardiomyocytes and with coronary capillaries, which consist only of microvascular endothelial cells. In both cell types, gpSUR2 was the dominant PCR signal (Fig. 2B) . gpSUR2⌬17 was also expressed, especially in endothelial cells. In accordance with the analysis of whole heart fraction, low amounts of gpSUR1, gpSUR1⌬19, and gpSUR1⌬17 were found in cardiomyocytes. The expression of the splice form lacking both exons, gp-SUR1⌬17⌬19, appeared to be restricted to cardiomyocytes because it was not observed in other tissues or in coronary capillaries. In endothelial cells, only gpSUR1 was detected but not (or only very weakly) the other gpSUR1 splice forms.
Identification of a short splice variant of SUR1. To isolate SUR1 from a guinea pig heart, we constructed a cDNA library and screened with a COOH-terminal guinea pig-specific SUR1 probe (29) . Several positive clones were identified and isolated. After the TriplEx DNA was converted from an isolated clone to pTriplEx, sequencing revealed a gpSUR1 cDNA 1,663 bp in length (GenBank accession no. AF183921). The 5Ј noncoding region (nucleotides 1-556) of this clone showed an as yet unknown sequence from bp 1 to 205 and continued with the known sequence of gpSUR1 starting at exon 28. The putative coding region of the cDNA (557-1552 bp) represents exons 31 (with a putative Start-Codon) to 39 of gpSUR1 and encodes a truncated gpSUR1 protein of 332 amino acids, which we named gpSUR1C. The deduced amino acid sequence contains only the last two putative transmembrane regions and the COOH-terminal domain of gpSUR1.
To exclude the possibility that the gpSUR1C clone is an artifact of cDNA synthesis, we confirmed the expression of this short gpSUR1 transcript with 5Ј RACE experiments. Figure 2C shows the RT-PCR analysis of several guinea pig tissues. gpSUR1C was found to be highly expressed in the atria and ventricles of guinea pig heart. At a lower expression level, gpSUR1C was detected in brain, lung, liver, kidney, and skeletal muscle. Cell-specific expression of gpSUR1C in the heart was studied by using the multicell RT-PCR method described previously (34) . gpSUR1C was found to be expressed exclusively in ventricular cardiomyocytes and not in endothelial cells from coronary capillaries, as illustrated in Fig. 2D .
SUR1 splice forms from rat. Because we have not cloned the entire SUR1 from guinea pig, we reconstituted the splice forms lacking exons 17 and 19 with the rat SUR1 cDNA (see MATERIALS AND METHODS). By amplifying a 690-bp fragment (ApaI-XhoI cassette) from different rat tissues, we were able to detect the rSUR1⌬17 and rSUR1⌬19 splice forms in this species as well (data not shown). However, we have not performed a detailed expression analysis in rat tissues. Although there are significant sequence differences between guinea pig and rat exons 17-18, including several amino acid substitutions and one insertion in exon 17 (see Fig. 1B ), the overall sequence identity (21 of 27 residues) and the conservation of alternative splicing are consistent with conserved functional properties. For further functional analysis, these rSUR1 splice forms (except for gpSUR1C) were used.
The novel SUR1 splice forms are not part of the mitochondrial K ATP channel. In recent years much work has been done to elucidate the molecular nature of the mitochondrial K ATP channel. To investigate the possibility that the novel SUR1 splice forms may be targeted to the mitochondria, we constructed several EGFP-fusion proteins of rSUR1, rSUR1⌬19, rSUR1⌬17, and gpSUR1C as well as Kir6.1. Figure 3 shows COS-7 cells labeled with the red fluorescent dye MitoTracker red (A) or transfected only with the subcellular localization markers MitoGFP but not with SUR or Kir6.1 subunits (B). MitoTracker red and MitoGFP were used as positive controls for targeting the mitochondria. It can be seen that the fluorescence of these two markers overlapped (Fig. 3C ), thus providing a reliable picture of the subcellular localization of mitochondria (Fig. 3, A-C) . To determine the morphology of the endoplasmic reticulum (ER), a YFP-tagged ER-marker was used (Fig. 3, D and E) . Figure 4 shows the fluorescence of COS-7 cells transfected with EGFP-tagged rSUR1, rSUR1⌬19, and rSUR1⌬17. No overlap with MitoTracker red fluorescence was seen for these EGFP-tagged splice forms. Re-cently, it has been suggested that the Kir6.1 subunit may be part of the mitochondrial K ATP channel (46) . Coexpression of the SUR1 splice forms with NH 2 -or COOHterminally EGFP-tagged Kir6.1, however, never resulted in a mitochondrial targeting of the Kir6.1 subunits, as illustrated in Fig. 5 . Figure 5 shows coexpression of Kir6.1-EGFP with rSUR1⌬17 (A-C) and coexpression of Kir6.1-EGFP with rSUR1⌬19 (D-F). Similar results were obtained for rSUR1 and gpSUR1C (not shown). In summary, our results suggest that SUR1 splice forms and Kir6.1 are not part of the mitochondrial K ATP channel. The sometimes diffusely labeled cytosol may indicate that EGFP-labeled K ATP channel subunits may not only be retained in the ER but may also be found in other vesicular structures yet to be characterized. (40) . We found no significant difference between membranes from cells transfected with pcDNA3.1 vector alone (control) and with rSUR1⌬19, rSUR1⌬17⌬19, and gpSUR1C. There was no difference in total binding between the different preparations (at 5 nM [ 3 H]GBC ϳ150 fmol/mg protein). Addition of 100 nM unlabeled GBC reduced total [ 3 H]GBC binding by ϳ5%; reduction after addition of 10 M GBC was 25-30%. Therefore, the binding measured for these splice forms was due to unspecific endogenous GBCbinding to the HEK-293 cells (20, 37) . On the other hand, specific binding of [ 3 H]GBC to rSUR1 and rSUR1⌬17 was detected (radioligand concentration 1 nM). In the absence of MgATP, total binding was 1.3-1.4 pmol/mg protein, and addition of 1 M unlabeled GBC reduced binding by 1.1-1.3 pmol/mg protein for rSUR1 and rSUR1⌬17. Because only (Fig. 6A, Table 1 ). The results obtained with rSUR1 and rSUR1⌬17 were not significantly different, with K d values of 0.2 nM in the absence of MgATP and 2.0 nM in the presence of 1 mM MgATP. Hill coefficients were close to 1 for all curves, indicating the presence of a single class of glibenclamide binding sites in each splice form. Specific binding of [ 3 H]GBC was inhibited to maximally 30% by MgATP in a concentration-dependent manner, giving very similar curves for both splice forms (Fig. 6B) . Both inhibition curves displayed two components with nearly the same amplitudes and IC 50 values of ϳ3 and 200 M (see Fig. 6B for precise parameters) . Control experiments in the presence of 1 mM EDTA or 1 mM EDTA ϩ 1 mM ATP showed that neither free magnesium nor free ATP affected (specific or nonspecific)
Inhibition of specific [ 3 H]GBC binding by another K ATP channel blocker, the benzoic acid derivative meglitinide, which binds to a subpocket of the glibenclamide binding site (4), was also investigated. Similar to the homologous competition by glibenclamide, displacement of specific [ 3 H]GBC binding by meglitinide (Fig. 7A ) occurred in a monophasic manner for both splice forms (Hill coefficients very close to 1 in all cases). Again, curves obtained in the absence of MgATP were shifted to the left compared with the curves obtained in the presence of 1 mM MgATP. Results obtained in the absence and in the presence of MgATP were significantly different for both rSUR1 (P Ͻ 0.001) and rSUR1⌬17 (P Ͻ 0.0001). On the other hand, there was no significant difference in the parameters obtained for rSUR1 and rSUR1⌬17 (Table 1) .
To test the binding properties of selected openers, inhibition of [ 3 H]GBC binding by unlabeled l-pinacidil and diazoxide was analyzed at 0 mM Mg 2ϩ and 1 mM EDTA and at 2.2 mM Mg 2ϩ and 1 mM ATP. Displacement of [ 3 H]GBC by both openers was found only in the presence of MgATP (Fig. 7B) , as has been shown previously (33, 41) . The curves obtained for both openers were very similar for rSUR1 and rSUR1⌬17.
Electrophysiological characterization. The ability of the splice forms to produce functional plasmalemmal K ϩ channels was tested in the whole cell configuration of the patch-clamp technique. Whereas 4 of 4 green fluorescent cells examined after transfection with Kir6.2 and rSUR1 developed a prominent inward current, no such currents were detected in 23 cells from two transfections with Kir6.2/gpSUR1C or in 18 cells transfected with Kir6.2/rSUR1⌬19.
Chutkow et al. (13) described differences in the potency of ATP block between channels containing SUR2 or SUR2⌬17. Therefore, the ATP sensitivities of Kir6.2/rSUR1 and Kir6.2/rSUR1⌬17 channels were compared in the inside-out patch-clamp configuration (Fig. 8) . As shown in Fig. 8A , rundown and refreshment of the channel in the presence of 0.7 mM free 
Mg
2ϩ led to some minor differences in ATP-block efficiency during repetitive application and washout of ATP. Therefore, the mean value of two successive runs was determined for each cell, and cells transfected with rSUR1 and with rSUR1⌬17 were subjected to exactly the same protocol. Figure 8B shows that there was no difference in ATP sensitivity between the two splice forms at low (270 nM) and physiological (0.7 mM) free Mg 2ϩ concentrations.
DISCUSSION
Alternative splicing of SUR is a functionally important mechanism for creating K ATP channel diversity. Most prominently, the differential usage of the two last SUR2 exons (38A and 38B) gives rise to channels with very different pharmacological properties (23, 25) . The SUR1 genes consist of 39 exons, only some of which can be spliced out without generating a frame shift. Several "spliceable" SUR exons are found within the coding region of the first NBF. Previous reports demonstrated skipping of exons 14, 17, and 18 of SUR2 (2, 13, 15) . In the present work we describe three novel splice variants of SUR1 in which the reading frames are preserved: SUR1⌬17, in which 36 bp are spliced out; SUR1⌬19, in which 99 bp are spliced out; and SUR⌬17⌬19.
The SUR1 splice forms lacking exons 17 and/or 19 were detected in various guinea pig and rat tissues, although in smaller amounts than SUR1 containing both exons 17 and 19. Different cell-specific expression patterns were found in the heart, indicating different regulation of alternative splicing in cardiac muscle cells and microvascular endothelial cells. The other novel splice variant, gpSUR1C, consisting only of exons 31-39 of SUR1, was found to be strongly expressed in cardiac atria and ventricles. Its expression appears to be restricted to cardiomyocytes because no PCR signal was obtained in the capillary fractions. This short splice variant has a predicted molecular mass of 36 kDa.
Because recent biochemical work has demonstrated that the molecular mass of the mitochondrial SUR is much smaller (29 kDa ered gpSUR1C as a potential candidate for the mitochondrial K ATP channel. However, the restricted expression pattern of gpSUR1C and the subcellular localization of the EGFP-tagged K ATP channel subunits make it very unlikely that gpSUR1C represents a subunit of the mitochondrial K ATP channel. Thus the functional role of this truncated splice form remains unclear. Our experiments with EGFP-tagged proteins suggest that none of the other novel SUR1 splice forms, rSUR1⌬17 and rSUR1⌬19, is targeted to the mitochondria, either alone or in combination with Kir6.1. By using immunogold labeling, Suzuki et al. (46) (42) who found 100% displacement in both cases. To explain this discrepancy, it has to be taken into account that experimental conditions (expression system, incubation time, and temperature) in these studies were different.
The characteristics of ATP inhibition of Kir6.2/ rSUR1 reported in the present study are in excellent agreement with a previous report (22) . Surprisingly, we observed no difference in ATP block of Kir6.2/ rSUR1 and Kir6.2/rSUR1⌬17 in either the presence or absence of free Mg 2ϩ . For the ⌬17 splice variants of SUR2A and SUR2B, however, Chutkow et al. (13) measured a reduced ATP sensitivity for channels containing Kir6.2 and SUR2x⌬17. Therefore, SUR1/ SUR1⌬17 clearly differ from SUR2/SUR2⌬17 in this respect. Because of the prominent differences of SUR1 and SUR2 in exon 17 itself and the neighboring region (Fig. 1) , a divergent behavior of the two proteins is plausible.
Our electrophysiological characterization of ATP and Mg 2ϩ sensitivity and our radioligand binding studies suggest that the lack of exon 17 does not affect functional expression of rSUR1 in the plasma membrane and its pharmacological properties. In contrast, exon 19 of rSUR1 appears to be essential for glibenclamide binding and functional channel expression because no specific glibenclamide binding was detected in the splice variants rSUR1⌬19 and rSUR1⌬17⌬19 and no K ATP currents were observed upon coexpression of Kir6.2 with rSUR1⌬17⌬19. Previous studies (4, 30) have shown that the region between transmembrane helix 14 and CL8 (the cytosolic loop linking helices 15 and 16) contribute to glibenclamide binding by interacting with the cyclohexyl ring of the glibenclamide molecule (4); in addition, CL3 (the cytosolic loop linking transmembrane helices 5 and 6) is important for high-affinity glibenclamide binding to SUR1 (30) . On the basis of the existing data, it cannot be decided Kd or Ki values are geometric means from 3-6 independent experiments; the 95% confidence interval is indicated in parentheses; A denotes the amplitude in %specific binding (Bs) with Bs Ϸ 1.3 pmol /mg protein in the absence of MgATP and Bs Ϸ 0.4 pmol/mg protein in the presence of MgATP. Experiments were performed as described in Figs. 6 and 7, and opener data were corrected for solvent. * Hill coefficient was set to 1 to allow unambiguous extrapolation of curve. GBC, [ 3 H]glibenclamide.
whether the region encoded by exon 19 represents an essential part of the glibenclamide binding site (e.g., for the benzamido or the sulfonylurea part of the molecule) or whether the absence of exon 19 affects glibenclamide binding indirectly, for example, by introducing a conformational change in the SUR1 molecule.
In conclusion, we have found three splice variants of SUR1 originating from alternative splicing of the region encoding NBF1 and a short splice variant containing only exons 31-39. The splice variants SUR1⌬17 and SUR1⌬19 were expressed in all tissues tested, albeit to a lesser amount than the SUR1 containing all exons. Only one of these splice forms, SUR1⌬17, showed glibenclamide binding and functional expression in combination with the pore-forming subunit Kir6.2. The short splice variant was found to be strongly expressed in cardiac muscle cells and displayed no high affinity for glibenclamide. Because none of the four novel splice variants was targeted to the mitochondria, they do not appear to participate in the formation of mitochondrial K ATP channels.
